Celcuity: Richard Buller

Cell-based diagnostics firm Celcuity has appointed Richard Buller to its board of directors, effective Dec. 3. Buller was most recently head of oncology clinical development and vice president of translational oncology at Pfizer before retiring in 2016. Before that, he was vice president of translational medicine at Exelixis.